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ABSTRACT
X-box binding protein 1 (XBP-1) is a key regulator
required for cellular unfolded protein response
(UPR) and plasma cell differentiation. In addition, in-
volvement of XBP-1 in host cell–virus interaction
and transcriptional regulation of viruses, such as
human T-lymphotropic virus type 1 (HTLV-1),
has been revealed recently. Two XBP-1 isoforms,
XBP-1U and XBP-1S, which share an identical
N-terminal domain, are present in cells. XBP-1S is
a transcription activator while XBP-1U is the inactive
isoform. Although the transactivation domain
of XBP-1S has been identified within the XBP-1S-
specific C-terminus, molecular mechanism of the
transcriptional activation by XBP-1S still remains
unknown. Here we report the interaction between
p300/CBP-associated factor (PCAF) and XBP-1S
through the C-terminal domain of XBP-1S. No
binding between XBP-1U and PCAF is detected. In
a cell-based reporter assay, overexpression of
PCAF further stimulates the XBP-1S-mediated
cellular and HTLV-1 transcription while knockdown
of PCAF exhibits the opposite effect. Expression of
endogenous XBP-1S cellular target genes, such as
BiP and CHOP, is significantly inhibited when PCAF
is knocked down. Furthermore, PCAF is recruited to
the promoters of XBP-1S target genes in vivo,i na
XBP-1S-dependent manner. Collectively, our results
demonstrate that PCAF mediates the XBP-1S-
dependent transcription through the interaction
with XBP-1S.
INTRODUCTION
X-box binding protein 1 (XBP-1) belongs to the cyclic
AMP response element binding protein/activating
transcription factor (CREB/ATF) family of transcription
factors. XBP-1 plays a major role in regulating unfolded
protein response (UPR), which is triggered when endo-
plasmic reticulum (ER) is under stress (1). XBP-1
has two protein isoforms, XBP-1U and XBP-1S. Both
isoforms share a common N-terminus containing a
basic-region leucine zipper (bZIP) domain which is
required for DNA binding. XBP-1U is the dominant
isoform under non-stress conditions. Activation of UPR
induces the endoribonuclease activity of inositol requiring
enzyme 1, an ER transmembrane protein, which removes
26 nts from the open-reading frame of XBP-1 mRNA (2).
This unconventional splicing occurs in cytoplasm and
causes a frame shift at amino acid 165 of XBP-1, leading
to the generation of XBP-1S by replacing the C-terminus
of XBP-1U with a strong transactivation domain (2,3).
XBP-1S is a transcription activator that up-regulates the
expression of ER chaperones and other genes involved in
membrane synthesis and the pathway of protein secretion
(4,5). Overexpression of XBP-1S increases the secretory
capacity of the cell and improves recombinant protein
productivity in secretion-limited mammalian cells by ex-
panding the surface area and volume of ER (5,6). It has
been shown recently that high-level expression of recom-
binant secreted proteins in cells and environmental
stresses during culture also induce the generation of
XBP-1S (7). XBP-1S is also found to be essential in the
terminal differentiation of the antibody producing plasma
cells by enhancing the secretory machinery of the cell (8,9).
The XBP-1-knockout B cells display impaired immuno-
globulin secretion, which can be restored by ectopic ex-
pression of XBP-1S (8). Furthermore, the involvement
of XBP-1 in tumorigenesis has been reported recently
(10–12).
Recent studies show that cellular UPR can be induced
by infection of various viruses, including Kaposi’s
sarcoma-associated herpesvirus (13), West Nile virus
(14), Japanese encephalitis virus (JEV) (15), hepatitis C
virus (16,17), human cytomegalovirus (HCMV) (18,19),
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spiratory syndrome coronavirus (21), coronavirus (22),
Epstein-Barr virus (23) and Semliki Forest virus (24).
Some viruses, such as JEV and DEN-2, use the ER of
host cells as the primary site of glycoprotein synthesis,
genomic RNA replication and virus particle maturation,
and thus trigger ER stress as well as UPR (15,20). In the
other case, some viral proteins, such as HCMV US11,
trafﬁc to the ER of host cells and induce UPR (18). The
transactivator of human T-lymphotropic virus type 1
(HTLV-1), Tax, has been shown to be localized in the
organelles associated with protein secretion including ER
and Golgi complex (25), raising the possibility that
HTLV-1 may affect cellular UPR as well. We previously
discovered that XBP-1S stimulates basal and
Tax-activated transcription of HTLV-1. Infection of
HTLV-1 was found to induce UPR and up-regulation
the expression of several UPR genes, including XBP-1.
Furthermore, XBP-1 was identiﬁed as one of the Tax
target genes in cells (26). Our results not only revealed a
positive feedback loop between HTLV-1 and the host
cells, but also suggested an important role for XBP-1 in
transcriptional regulation of HTLV-1.
The localization of a transactivation domain within the
C-terminus of XBP-1S helps to explain the transactivating
ability of XBP-1S. However, the molecular mechanism of
XBP-1S transactivation still remains to be determined.
One possibility is that the C-terminus of XBP-1S may
interact with a speciﬁc cellular co-activator, which is re-
sponsible for the up-regulation of XBP-1S target genes.
Here, we identify a histone acetyltransferase (HAT),
p300/CBP-associated factor (PCAF), as a XBP-1S-
speciﬁc binding protein and demonstrate the functional
signiﬁcance of the PCAF-XBP-1S interaction in the
XBP-1S-mediated transcription.
MATERIALS AND METHODS
Cells, short interfering RNAs, short hairpin RNAs
and plasmids
HEK293, 293T and MCF7 cells were obtained from
American Type Culture Collection. The short interfering
RNAs (siRNAs) targeting PCAF (siPCAF-6: 50-CGGAG
TGTACTCCGCCTGCAA-30 and siPCAF-7: 50-CAGCA
AATAATTGTCAGTCTA-30) and p300 (sip300-7
siRNA: 50-TTGGACTACCCTATCAAGTAA-30 and
sip300-10: 50-CCCGGTGAACTCTCCTATAAT-30) were
purchased from Qiagen, and the short hairpin RNAs
(shRNA) against PCAF (shPCAF: 50-TAGATGAGGT
GCTTTGAGCAGTTCTGAAA-30) was obtained from
Origene. Human XBP-1S and XBP-1U expression
plasmids were previously described (26). The plasmids
for expression of human PCAF and p300 were obtained
from Open Biosystems. The plasmids containing a series
of hemagglutinin (HA) tagged XBP-1 deletions were
generous gifts from Dr Hiderou Yoshida (27). The ﬁreﬂy
luciferase reporter plasmids, HTLV-Luc and BiP-Luc
[including wild-type and ER stress response (ERSE)
mutant BiP-Luc plasmids], were kindly provided by
Dr Arnold Rabson and Dr Kazutoshi Mori, respectively
(28,29).
Transient transfection and luciferase assays
Transient transfections of DNA plasmids into HEK293,
293T and MCF7 cells were performed using FuGENE 6
(Roche) according to the manufacturers’ instructions. To
perform the cell-based overexpression assays, cells were
grown to 50–80% conﬂuence in 96-well plates and
co-transfected with a luciferase reporter and an expression
plasmid. Lipofectamine 2000 Reagent (Invitrogen) was
utilized to co-transfect cells with DNA plasmids and
siRNAs for the cell-based knockdown experiments.
Fireﬂy luciferase activities were measured 48 h
post-transfection using the Bright-Glo assay system
(Promega) and the activities were determined using an
Inﬁnite 200 multiplate reader (Tecan). HEK293 cells
were used in the cell-based luciferase assays.
Co-immunoprecipitation and western blotting
293T cells were transiently co-transfected with indicated
expression plasmids and the cell lysates were prepared 2
days post-transfection for co-immunoprecipitation
(Co-IP). To get the high levels of ectopic expression,
293T, a highly transfectable derivative of HEK293, was
chosen for the Co-IP study. The IP kit was purchased
from Roche and Co-IP was performed according to the
manufacturers’ instructions. The immunoprecipitated
complexes were analyzed by western blotting. Western
blotting was carried out according to the standard proto-
cols. All the antibodies used in our study were obtained
from Santa Cruz Biotechnology, except the anti-HA
antibody (Sigma).
Quantitative reverse transcriptase-polymerase
chain reaction
The UPR inducing compounds, tunicamycin (Tm) (Assay
Designs) and thapsigargin (Tg) (Sigma), were dissolved in
dimethyl sulfoxide (DMSO) to 10mg/ml and 3mM,
respectively. All three cell lines, HEK293, 293T and
MCF7, exhibited UPR after treating with Tm or Tg.
Induction of the UPR genes in the treated cells were con-
ﬁrmed by quantitative reverse transcriptase-polymerase
chain reaction (QRT–PCR) (data not shown). Among the
cell lines used in this study, the endogenous XBP-1S target
genes in MCF7 cells showed the highest sensitivity to the
ectopic expression of XBP-1S (data not shown). Therefore,
MCF7 cells were selected for the XBP-1S overexpression
experiments followed by the examination of the transcrip-
tional regulation of XBP-1S-dependent genes in vivo. Total
RNAs of the transfected MCF7 cells or the Tm (10mg/ml)/
Tg (300nM) treated HEK293 cells were isolated using
RNeasy mini kit (Qiagen). One microgram of the total
RNAs was converted into complementary DNA (cDNA)
using ImProm
TM-II Reverse Transcription System
(Promega). Speciﬁc cDNAs were ampliﬁed using SYBR
Green PCR Master Mix (Applied Biosystems). The
primer pairs used in this study include: BiP (50-
GGTGAAAGACCCCTGACAAA-30 and 50-GTCAGG
CGATTCTGGTCATT-30), CHOP (50-CTTCTCTGG
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CTT-30), EDEM (50-AGGTGCTGATAGGAGATG
TGG-30 and 50-GGATTCTTGGTTGCCTGGTA-30) and
glyceraldehyde 3-phosphate dehydrogenase (GAPDH)
(50-AACAGCCTCAAGATCATCAGC-30 and 50-GGAT
GATGTTCTGGAGGACC-30). GAPDH was used as a
control to normalize the cDNA inputs. Ampliﬁcation and
detection of the cDNAs were performed using ABI Prism
7000 Thermal-Cycler (Applied Biosystems).
Quantitative chromatin immunoprecipitation
Chromatin immunoprecipitation (ChIP) assays were
carried out using EZ ChIP kit (Millipore) according to
the manufacturer’s protocol with some modiﬁcations.
HEK293 cells were treated with Tm (10mg/ml) or Tg
(300nM) for 16 h prior to cross-linking. DNA fragments
at around 200–1000bp were achieved by sonication with
Microson Ultrasonic Cell Disruptor (Misonix). For the
IP, the indicated antibodies (i.e. anti-XBP-1 or
anti-PCAF antibodies) were added to the sheared chro-
matin individually and incubated at 4 C overnight. The
DNA/protein/antibody complex was then pulled down by
protein G agarose and the DNA in the complex was
puriﬁed using QIAquick PCR puriﬁcation kit (Qiagen).
Quantitative-PCR was performed to determine the
relative amount of DNA that was immunoprecipitated
by anti-XBP-1 or anti-PCAF antibodies in the presence
of Tm or Tg. The primer pairs used to amplify the
promoter regions of BiP and CHOP genes include: BiP
(50-GATGGGGCGGATGTTATCTA-30 and 50-CTCT
CACACTCGCGAAACAC-30) and CHOP (50-GACA
CTACGTCGACCCCCTA-30 and 50-GGTTCCAGCTC
TGATTTTGG-30). Cells treated with DMSO were
served as a negative control. For the overexpression
study, MCF7 cells were co-transfected with a PCAF ex-
pression vector and one of the XBP-1 plasmids (XBP-1S
or XBP-1U plasmids) 2 days prior to cross-linking. Cells
co-transfected with a PCAF plasmid and an empty vector
served as a negative control.
Statistical analysis
The data shown (including luciferase assays, QRT–PCR
and quantitative ChIP) were analyzed using Student’s
t-test at 5% signiﬁcance level (P<0.05).
RESULTS
XBP-1S interacts with PCAF through its C-terminal
transactivation domain
We previously demonstrated that XBP-1S, a member of
CREB/ATF family proteins, stimulates basal and
Tax-activated HTLV-1 transcription (26). It has been
reported that two histone acetyltransferases (HATs),
PCAF and p300, are required to activate HTLV-1 tran-
scription through three 21-bp repeats known as Tax-
responsive element (TRE) located with the HTLV-1
promoter (30). Each TRE contains a binding site for
CREB/ATF proteins, suggesting a potential functional
connection between HATs and XBP-1S. We ﬁrst
investigated the interaction between PCAF and two
XBP-1 isoforms. Cells were transfected with an XBP-1S
or XBP-1U expression plasmid followed by IP analyses
Figure 1. PCAF associates with XBP-1S. (A) 293T cells were transfected with an expression plasmid to ectopically express XBP-1S, XBP-1U and
CREB1, respectively. IP was performed using the cell lysates prepared from the transfected cells and the indicated antibodies. Normal IgG (IgG) was
used as a negative control. The immunoprecipitated complexes and the protein inputs were analyzed by western blotting. (B) The cell lysates of
XBP-1S expressing cells were used for IP with an anti-PCAF antibody. The presence of XBP-1S in the immunoprecipitates was determined by
western blotting. (C) Cells were co-transfected with a p300 expression vector and an indicated plasmid (i.e. XBP-1S, XBP-1U, and CREB1 plasmids,
respectively). IP was carried out using an anti-p300 antibody followed by western blotting.
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can recognize both XBP-1 isoforms. The association
between PCAF and another member of CREB/ATF
protein family, CREB1, was also examined (Figure 1A).
PCAF was found in the immunoprecipitated complexes of
XBP-1S expressing cells, but not in XBP-1U or CREB1
expressing cells (Figure 1A). Reciprocal IP was carried out
using an anti-PCAF antibody and XBP-1S was detected in
the immunoprecipitated complexes, conﬁrming the inter-
action between PCAF and XBP-1S (Figure 1B).
Interaction between XBP-1S and another HAT, p300,
was examined next. However, no association between
p300, XBP-1S, XBP-1U and CREB1 was detected
(Figure 1C), indicating a speciﬁc binding between PCAF
and XBP-1S.
Domain study of XBP-1 was carried out using a series
of HA-tagged XBP-1 truncations (Figure 2A). Cells were
transfected with an individual XBP-1 truncation plasmid
followed by IP using anti-PCAF antibodies. As shown in
Figure 2B, only the XBP-1S-speciﬁc C-terminal region,
which contained the transcriptional activation domain of
XBP-1S, was found to associate with PCAF, but not the
XBP-1U-speciﬁc C-terminus or any other regions of
XBP-1. The heavy chains of anti-PCAF antibodies were
also recognized by the secondary antibody used for the
immunoblotting. Since the molecular weights of heavy
chains and HA-tagged XBP-1S were similar ( 50kDa),
the blot could not reveal the presence of HA-XBP-1S in
the immunoprecipitates. We did another western blot
using an anti-XBP-1S antibody recognizing the common
domain of XBP-1S and XBP-1U and conﬁrmed the inter-
action between PCAF and HA-XBP-1S (Figure 2B, the
anti-XBP-1 blot). It was noted that the interaction
between PCAF and endogenous XBP-1S proteins were
also detected in the HA-1S(134–376)- and HA-XBP-
1U-transfected cells (Figure 2B). Collectively, the results
demonstrate that PCAF binds to XBP-1S through the
transcriptional activation domain of XBP-1S located in
its C-terminal region.
PCAF is required for XBP-1S-mediated activation of
HTLV-1 and BiP transcription
Functional signiﬁcance of the PCAF-XBP-1S interaction
was assessed in the XBP-1S-dependent transcription
assays. XBP-1S is known to regulate the transcription of
HTLV-1 and cellular gene BiP (4,26). The luciferase re-
porters, in which the expression of luciferase was driven by
HTLV-1 and BiP promoters (i.e. HTLV-Luc and BiP-Luc,
respectively), were utilized in the study. In the XBP-1S
co-transfected cells, more than 10-fold increases in
luciferase expression were observed in HTLV-1 and BiP
promoters (Figure 3A and B). Further induction (more
than 2-fold) of the XBP-1S-mediated activation of
HTLV-1 and BiP promoters was detected in the
PCAF-expressing cells (Figure 3A and B). However,
overexpression of p300 had no signiﬁcant effects on
XBP-1S-dependent transcription (Figure 3A and B).
The impact of PCAF knockdown on the activation of
HTLV-1 and BiP transcription by XBP-1S was studied
next. The knockdown experiments were carried out
using the siRNAs speciﬁcally targeting PCAF. The effect-
iveness of two PCAF siRNAs, PCAF-6 and PCAF-7, was
conﬁrmed by western blotting (Figure 4A). Two p300
siRNAs (i.e. p300-7 and p300-10) were utilized as
controls since no association between p300 and XBP-1S
was observed (Figure 1C). However, the protein levels of
endogenous p300 in the cells were not high enough to be
clearly revealed by western analyses. QRT–PCR was then
used to conﬁrm the actions of two p300 siRNAs. Forty to
ﬁfty percent decrease in p300 mRNA levels were detected
in the cells transfected with the p300 siRNAs (data not
shown).
Cells were co-transfected with the luciferase reporter
(i.e. HTLV-Luc or BiP-Luc), a XBP-1S plasmid, and an
indicated siRNA (Figure 4B and C). Compared to the
transfection excluding the XBP-1S expression vector, 6-
and 18-fold enhancement in the activation of HTLV and
BiP promoters was observed (Figure 4B and C, the ﬁrst
two transfections). The GL3 siRNA, which speciﬁcally
targeted the GL3 luciferase used in the HTLV-Luc and
BiP-Luc reporters, was used as a positive control and
caused 90% decreases in luciferase expression under the
control of HTLV and BiP promoters (Figure 4B and C,
the second and third transfections). The two PCAF
siRNAs inhibited  40% luciferase expression driven by
Figure 2. Domain study of XBP-1. (A) Diagram of XBP-1 truncations.
All the constructs were HA-tagged. (B) 293T cells were transfected with
the indicated plasmid to express an individual XBP-1 deletion. IP was
performed using the anti-PCAF antibody followed by western blotting
with anti-HA or anti-XBP-1 antibodies.
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by either p300 siRNA (Figure 4B). Similar observations
were found in the BiP-Luc reporter assays (Figure 4C).
Results obtained from the PCAF overexpression and
knockdown reporter assays (Figures 3 and 4) demonstrate
the functional involvement of PCAF in the genes
regulated by XBP-1S.
XBP-1S regulates the transcription of BiP by binding
to the ERSE element located within the BiP promoter
(2,31). We next wished to determine if the transcriptional
activation of the BiP promoter by PCAF was mediated
through ERSE as well. The wild-type and ERSE-mutant
BiP-Luc reporter plasmids were utilized in the experiments.
Extopic expression of PCAF signiﬁcantly activated the Luc
expression driven by the wild-type BiP promoter, while
little or no effects were detected on the transcription
driven by the ERSE-mutant BiP promoter (Figure 5A).
Since the protein level of endogenous XBP-1S was low in
the ER stress-free cells, only up to a 44% increase in BiP
transcription was observed (Figure 5A). In the XBP-1S-
overexpressing cells, PCAF exhibited stronger activation
on the expression of luciferase driven by the wild-type BiP
promoter (Figure 5B, up to 3-fold). However, noactivating
effects on the ERSE mutant BiP promoter were detected
when both PCAF and XBP-1S were overexpressed (Figure
5B). Collectively, these results suggest that PCAF interacts
with XBP-1S and mediates BiP transcription in an
ERSE-dependent manner.
PCAF mediates the transcription of endogenous XBP-1S
target genes
Requirement for PCAF in the mediation of endogenous
XBP-1S target genes, including BiP, CHOP and EDEM
(4), was investigated. We performed QRT–PCR assays to
determine the impact of PCAF on the activation of
XBP-1S target genes by knocking down the expression
of PCAF. Compared to the DNA transfection,
co-transfection of DNA plasmids and siRNAs was much
Figure 4. Knockdown of PCAF inhibits XBP-1S-mediated
transcription. (A) Cell lysates of the PCAF siRNA-transfected
HEK293 cells were analyzed by western blotting to determine the
effectiveness of the siRNAs. Cells transfected with a non-speciﬁc
siRNA were used as a negative control (i.e. Con.). For the
luciferase-based assays, HEK293 cells were transiently co-transfected
with a luciferase reporter [(B) HTLV-Luc and (C) BiP-Luc], a
XBP-1S expression plasmid, and an indicated siRNA. The siRNAs
used for the experiments included non-speciﬁc (i.e. Con.), luciferase
(i.e. GL3), two PCAF (i.e. PCAF-6 and PCAF-7) and two p300
(i.e. p300-7 and p300-10) siRNAs. *P<0.05 versus control (i.e. cells
co-transfected with a control non-speciﬁc siRNA and a XBP-1S expres-
sion plasmid).
Figure 3. Overexpression of PCAF stimulates XBP-1S-mediated
transcription. HEK293 cells were transiently co-transfected with a
luciferase reporter [(A) HTLV-Luc and (B) BiP-Luc] and indicated ex-
pression plasmids (i.e. XBP-1S, PCAF and p300). The amounts of
PCAF and p300 plasmids were titrated at 3-fold increment. The total
amounts of plasmids transfected were kept constant by adjusting the
mock vector. *P<0.05 versus control (i.e. cells transfected with a
XBP-1S expression plasmid).
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plasmid against PCAF was used to co-transfect cells
along with an XBP-1 expression vector. Effectiveness of
the PCAF shRNA was conﬁrmed by western blotting
(Figure 6A). Overexpression of XBP-1S resulted in 3- to
4-fold increases in the mRNA levels of BiP, CHOP, and
EDEM (Figure 6B). Co-transfection of the PCAF shRNA
in the XBP-1S-expressing cells led to 35, 74 and 52% in-
hibition of BiP, CHOP, and EDEM transcription, respect-
ively (Figure 6B), demonstrating the involvement of
PCAF in the XBP-1S-dependent transcription.
The in vivo recruitment of PCAF to the XBP-1S en-
dogenous target genes was examined next. Cells were
transfected with a PCAF expression plasmid and an
indicated vector (i.e. empty, XBP-1U, and XBP-1S
plasmids). Distribution of PCAF and XBP-1 on the pro-
moters of BiP and CHOP was analyzed by quantitative
ChIP. Fewer XBP-1 and PCAF proteins were located on
BiP and CHOP genes when XBP-1U was overexpressed
(Figure 7A and B). In the XBP-1S/PCAF co-transfected
cells, more XBP-1S proteins were found to bind to the
promoter region of BiP and CHOP genes (Figure 7A
and B). It was expected since overexpression of XBP-1S
activated the transcription of BiP and CHOP (Figure 6B).
In addition, a 3-fold increase in PCAF binding to BiP
and CHOP genes was detected in the XBP-1S/PCAF
co-expressing cells (Figure 7A and B), providing the
evidence that PCAF was recruited to BiP and CHOP
promoters through the interaction with XBP-1S.
Involvement of PCAF in the UPR-dependent activation
of XBP-1S
UPR induces the generation of XBP-1S which
up-regulates its target genes required for secretory
pathway, membrane synthesis, protein folding and
ER-associated degradation (1). The involvement of
PCAF for XBP-1S activation during UPR was studied
by examining the expression BiP and CHOP genes. Cells
were transfected with a control or PCAF shRNA followed
by the treatment of Tm to induce UPR. The mRNAs
isolated from the cells were analyzed by QRT–PCR. The
mRNA levels of BiP and CHOP increased 4- and 14-fold,
respectively, after Tm incubation (Figure 8A).
Knockdown of PCAF only led to minor inhibition on
the transcription of the two genes (Figure 8A). An identi-
cal set of assays was performed using Tg as the UPR
Figure 5. Transcriptional activation of the BiP promoter by PCAF is
mediated through ERSE. (A) HEK293 cells were transfected an
indicated BiP-Luc reporter (i.e. wild-type or ERSE mutant) and a
PCAF expression plasmid. Amounts of the PCAF plasmids were
titrated at 3-fold increment. *P<0.05 versus control (i.e. cells trans-
fected with an empty plasmid and a wild-type BiP-Luc reporter). (B)
HEK293 cells were co-transfected an indicated BiP-Luc reporter, a
XBP-1S expression plasmid, and a PCAF expression plasmid (at
3-fold increment). *P<0.05 versus control (i.e. cells transfected with
an XBP-1S plasmid and a wild-type BiP-Luc reporter).
Figure 6. Knockdown of PCAF inhibits the transcription of endogen-
ous XBP-1S target genes. (A) MCF7 cells were co-transfected with the
indicated plasmid (i.e. empty or XBP-1S expression vectors) and
shRNA [i.e. non-speciﬁc (Con.) or PCAF]. Expression of PCAF and
XBP-1S was analyzed by western blotting. (B) The mRNAs of the
XBP-1S target genes, including BiP, CHOP and EDEM were quantiﬁed
by QRT–PCR. Cells transfected with an empty vector and a
non-speciﬁc shRNA served as a negative control. Knockdown of
PCAF using a speciﬁc PCAF shRNA exhibited signiﬁcant decreases
in the expression of BiP CHOP, and EDEM, respectively (*P<0.05
versus cells co-transfected with a control non-speciﬁc shRNA and a
XBP-1S expression plasmid).
434 Nucleic Acids Research, 2011,Vol. 39,No. 2inducing reagent. Little or no signiﬁcant effects on BiP
and CHOP mRNAs were detected in the PCAF
shRNA-transfected cells (Figure 8B). We further carried
out quantitative ChIP to examine the distribution of
XBP-1S and PCAF on BiP and CHOP genes during
UPR. Incubation of Tm resulted in 15- and 5-fold in-
creases in XBP-1S binding to BiP and CHOP promoters,
respectively, while only 3- and 1.7-fold increases in PCAF
associating with the two genes (Figure 8C). In another set
of experiments with Tg treatment, <2-fold increases in
PCAF binding to endogenous BiP and CHOP genes
were detected, while more than 20- (BiP) and 5-fold
(CHOP) enhancement in XBP-1S binding (Figure 8D).
Taken together the QRT–PCR and quantitative ChIP
analyses suggest the limited involvement of PCAF in the
mediation of XBP-1S target genes during UPR.
Induction of UPR has no effects on the association
between XBP-1S and PCAF
A recent study demonstrated that the association between
XBP-1S and its binding protein could be UPR-dependent
and such protein–protein interaction was disrupted after
treating cells with UPR-inducing compound, Tm (32). We
examined the inﬂuence of UPR on the PCAF-XBP-1S
interaction by treating cells with Tm followed by IP
analyses. No changes in the binding of PCAF to
XBP-1S were detected under the treatment of Tm
(Figure 9), suggesting the existence of the PCAF-XBP-
1S protein complexes during UPR.
DISCUSSION
In this study, we investigate the molecular mechanism to
elucidate the distinct functions between the inactive
XBP-1U and active XBP-1S. Both isoforms have an
identical N-terminus and an isoform-speciﬁc C-terminal
region (Figure 2A). We identify PCAF as a novel
XBP-1S binding protein and demonstrate the biological
importance of PCAF in regulating the XBP-1S-mediated
cellular and viral transcription. PCAF binds to XBP-1S
through the interaction with the XBP-1S-speciﬁc
C-terminal domain but fails to associate with the
full-length XBP-1U or the XBP-1U-speciﬁc C-terminus
(Figures 1 and 2), providing an explanation for the
transactivating ability of XBP-1S on gene expression.
Basal transcription of HTLV-1 occurs after proviral
integration into the host cell genome and induces the
initial expression of HTLV-1 proteins, including the
transactivator, Tax, followed by Tax transactivation to
boost the synthesis of viral transcripts. Two HATs,
PCAF and p300, have been shown to interact with Tax
and play a role in Tax-activated viral transcription
(26,33–35). Tax, which does not bind to DNA by itself,
activates HTLV-1 transcription through three 21-bp
repeats known as TRE, located within the promoter of
HTLV-1. Each 21-bp TRE repeat contains a CREB/
ATF binding site and is known to associate with CREB/
ATF family proteins (36,37). Tax binds to TREs through
the interaction with CREB/ATF family proteins
(including XBP-1S, CREB1 and CREB2) and recruits
PCAF/p300 to HTLV-1 promoter, resulting in Tax trans-
activation (26,33–35). We previously found that XBP-1S
bound to Tax and induced stronger Tax transactivation
than other CREB/ATF family proteins (26). Interestingly,
XBP-1S also stimulated basal transcription of HTLV-1,
while CREB1 and CREB2 did not show any activating
effects, suggesting a crucial role for XBP-1S during the
early phase of viral transcription as well (26). No inter-
action between PCAF and CREB1 was detected in Co-IP
analyses (Figure 1A). This observation could explain why
CREB1 and other CREB/ATF family proteins fail to
up-regulate HTLV-1 transcription in the absence of Tax.
In contrast, the requirement for PCAF in the
XBP-1S-dependent HTLV-1 basal transcription was
clearly demonstrated in the cell-based reporter assays
(Figures 3A and 4A).
Functional signiﬁcance of PCAF-XBP-1S interaction
on the cellular target genes of XBP-1S, including
BiP, CHOP and EDEM, was demonstrated in the
PCAF overexpression and knockdown experiments
(Figures 3–6). In addition, quantitative ChIP assays
showed that XBP-1S recruited PCAF to the promoters
of endogenous XBP-1S target genes in vivo, establishing
direct functional connection between PCAF and XBP-1S
(Figure 7). However, knockdown of PCAF by siRNA or
shRNA did not completely inhibit the elevated transcrip-
tion caused by XBP-1S (Figures 4 and 6). There are two
Figure 7. XBP-1S recruits PCAF to the target genes of XBP-1S in vivo.
MCF7 cells were co-transfected with a PCAF expression vector and an
indicated plasmid [i.e. empty (pcDNA6), XBP-1U, or XBP-1S]. ChIP
was carried out followed by quantitative PCR to quantify the binding
of XBP-1S and PCAF to the promoters of BiP (A) and CHOP (B).
Cells transfected with an empty vector and a PCAF plasmid was used
as a negative control. *P<0.05 versus negative controls.
Nucleic AcidsResearch, 2011, Vol.39,No. 2 435possible explanations for these observations. First, both
siRNA and shRNA against PCAF did not completely
block the protein synthesis of PCAF (Figures 4A
and 6A). Therefore, it is possible that the siRNA- and
shRNA-transfected cells still have sufﬁcient PCAF
left to participate in the gene activation by XBP-1S.
Secondly, PCAF may be one of the cellular co-factors re-
sponsible for XBP-1S-dependent transcription. Therefore,
elimination of PCAF by RNA interference could only
partially inhibit the transactivation of XBP-1S.
Discovery of the involvement of PCAF in the transcrip-
tional regulation of BiP and EDEM genes is novel. PCAF
has been identiﬁed as a co-factor of ATF4 (or CREB2) for
the expression of CHOP (38). In response to amino acid
starvation, ATF4 binds to the amino acid response
element located in the CHOP promoter and recruits
PCAF to the promoter, leading to the activation of
CHOP transcription (38). Besides PCAF, ATF4 also inter-
acts with other HATs, including p300 and CBP, through
its N-terminal transactivation domain (39,40). As shown
in Figure 1, XBP-1S shows more stringent protein binding
than ATF4 and fails to associate with p300. Future study
is required to investigate the interaction between XBP-1S
and other HATs to further determine the binding speciﬁ-
city of the XBP-1S transactivation domain. Collectively,
Figure 8. Requirement of PCAF for the mediation of XBP-1S target genes under UPR. MCF7 cells were co-transfected with a non-speciﬁc
(i.e. control) or PCAF shRNA, and incubated with 10mg/ml Tm (A) or 300nM Tg (B). Both Tm and Tg were dissolved in DMSO and the ﬁnal
concentration of DMSO in the culture was kept at 0.1%. Expression of endogenous BiP and CHOP genes was determined by QRT–PCR. Cells
transfected with a control shRNA with 0.1% DMSO were served as a negative control. For quantitative ChIP assays, HEK293 cells were treated
with 10mg/ml Tm (C) or 300nM Tg (D) and the bindings of XBP-1S and PCAF to the endogenous BiP and CHOP genes were analyzed by
quantitative PCR. Cells incubated with 0.1% DMSO were used as a negative control. Fold changes were determined by comparing to the negative
controls. *P<0.05 versus negative controls.
Figure 9. Interaction between XBP-1S and PCAF under UPR. 293T
cells were transiently transfected with a XBP-1S expression vector and
incubated with 10mg/ml Tm or 0.1% DMSO (i.e. the negative control)
for 16 h. IP was performed using the cell lysates prepared from the
transfected cells and the antibody against XBP-1. Normal IgG (IgG)
was used as a negative control. The immunoprecipitated complexes and
the protein inputs were analyzed by western blotting.
436 Nucleic Acids Research, 2011,Vol. 39,No. 2the ﬁndings by our and other groups point out that PCAF
may play an important role in transcriptional activation of
CHOP through the XBP-1S- as well as ATF4-dependent
pathways.
It has been reported that p300 is recruited to the en-
dogenous BiP promoter in the Tg-treated cells by ChIP
assays (41). Co-overexpression of p300, YY1 and ATF6
showed synergistic activation of luciferase expression
driven by the BiP promoter, suggesting that p300 might
be required for YY1-/ATF6-mediated activation of BiP
(41). Similar cell-based reporter assays (i.e. using the
BiP-Luc reporter plasmid) were performed to determine
the requirement of p300 for XBP-1S-mediated transacti-
vation. Neither overexpression nor knockdown of p300
showed any signiﬁcant effects on XBP-1S-dependent
luciferase expression (Figures 3 and 4), suggesting that
p300 might function in a XBP-1S-independent manner.
These results were further supported by Co-IP data, in
which no interaction between p300 and XBP-1S was
detected (Figure 1C). Furthermore, we assessed the re-
quirement of p300 for transcriptional activation of BiP
and CHOP genes under UPR. In contrast to the report
by Baumeister et al. (41), our results obtained from the
quantitative ChIP analyses did not show any increased
p300 binding to either BiP or CHOP promoters in the
Tm- or Tg-stressed cells (data not shown), raising the
questions regarding to the involvement of p300 in the
regulation of XBP-1S target genes.
Under the ER stress-free condition, our data clearly
indicated that PCAF was required for XBP-1S-mediated
transcriptional regulation (Figures 3–7). However, results
from QRT–PCR and quantitative ChIP showed that
PCAF only exhibited limited involvement in the expres-
sion of XBP-1S target genes when UPR was induced
(Figure 8). A recent study identiﬁed the regulatory
subunit of phosphoinositide 3-kinase (PI3K) as a novel
XBP-1S binding protein and demonstrated that the asso-
ciation between XBP-1S and the PI3K subunit could be
UPR-dependent (32). We examined the XBP-1S-PCAF
protein–protein interaction under the normal or
Tm-stressed conditions. As shown in Figure 9, the inter-
action between XBP-1S and PCAF was not disrupted
during UPR. On-going research focuses on the identiﬁca-
tion of the XBP-1S co-factor(s) required for the transac-
tivation caused by XBP-1S once UPR is induced. GCN5,
a HAT which shares 73% identity in amino acid sequence
with PCAF (42), is a possible candidate for XBP-1S
binding partner. The involvement of GCN5 in
XBP-1S-dependent transcription and during UPR is cur-
rently under investigation.
The tumor microenvironment is hypoglycemic and
hypoxic, resulting in induction of UPR and
overexpression of XBP-1. Recent studies show the in-
volvement of XBP-1 in tumorigenesis of various cancers
and suggest XBP-1 as a potential target for anti-cancer
therapeutics (10–12,43). Fujimoto et al. investigated the
expression of XBP-1 in 11 primary breast cancers and
ﬁve breast cancer cell lines, including MCF7. The
increased expression of XBP-1 was detected in all breast
cancers and cell lines examined, but not in the
non-cancerous breast issue (44). In addition, clinical
results showed that high levels of XBP-1S increased the
survival of breast cancers (45). Our data presented here
demonstrate the functional importance of PCAF in
mediating the expression of XBP-1S target genes in
MCF7 cells (Figures 6 and 7), suggesting a potential role
of PCAF in XBP-1S-mediated tumerigenesis of breast
cancers. Furthermore, PCAF may be an essential factor
for other XBP-1S-mediated signaling pathways. For
example, XBP-1S is one of the key components in the
transcriptional program controlling plasma cell differenti-
ation (1). It would be worthwhile to examine the import-
ance of PCAF-XBP-1S during the development of plasma
cells.
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